The Grand opening event was held on 15th May 2018 and was a great opportunity for the company to not only showcase the new, state-of-the art lab and office spaces but also update the shareholders and guests on how far Neuro-Bio has progressed in its novel approach to Alzheimer’s Disease.
The event saw speakers present a wide range of viewpoints, both from scientific and personal and these are detailed below.
Speech provided by Mr Eric Abbott
Eric was a carer for his late-wife who suffered from Alzheimer’s. After her passing he volunteer his time to Alzheimer’s Society after they had helped him so much when his wife was first diagnosed. Eric helps at carer support meetings where they discuss problems they have encountered or require assistance and advice. Eric is also a research volunteer with the Research Network section of the Alzheimer’s Society at their Head Office in London, and provides talks to various organisations about dementia and the effect that it has on the individual.
Interview with Ms Kleyn by Lord Arbuthnot
The interview by Lord Arbuthnot asked Ms Kleyn about what it was like to have a family member that had been diagnosed with Alzheimer's Disease.She discussed how early signs were shown but not attributed to Alzheimer's at the time. With retrospect and further understanding of the Disease she recognises now how early the effects started to show.
Speech provided by Professor Esiri
Professor Margaret Esiri DM is Emeritus Professor of Neuropathology at Oxford University and continues to work part-time on research relating to neurodegeneration and dementia, which she has been interested in for the last 30 years. Earlier in her career she was an MRC Senior Clinical Fellow and then Professor of Neuropathology at Oxford and Honorary Consultant Neuropathologist at the Oxford University Hospitals. Most of her work has been based on the study of autopsied human brain tissue. Her speech summarised the current clinical state of Alzheimer’s Disease and how she came to be involved with Neuro-Bio.
Speech provided by Baroness Greenfield, CBE
Baroness Greenfield, Founder and CEO of Neuro-Bio Ltd is British research scientist, author and broadcaster. Baroness Greenfield has published over 200 papers in peer-reviewed journals over the course of her distinguished career. She holds 32 honorary degrees from UK and foreign universities, and has received numerous honours including the Legion d’Honneur from the French Government. Susan also has an Honorary Fellowship from the Royal College of Physicians, American Academy of Achievement Golden Plate Award, and is a member of the Fellowship of the Royal Society of Edinburgh. Baroness Greenfield provided an overview of Neuro-Bio, of what we are striving to achieve and how.
Between speeches audience members were able to listen to videos of Mr Yates AM, Dr Gregory Cole and Dr Richard Mohs. They provided insight on why they chose to support Neuro-Bio Ltd and explaining why an Alzheimer’s treatment is necessary.
Mr Peter Yates is Deputy Chairman of The Myer Family Investments Pty Ltd and a Director of AIA Australia Limited. He is also the Chairman of the Boards of the Royal Children’s Hospital Foundation, the Faculty of Business and Economics at Melbourne University, The Royal Institution of Australia, the Australian Science Media Centre and the Shared Value Project. In June 2011 Queen’s Birthday Honours, Peter was awards as a Member of the Order of Australia for services in the financial services industry, education and a range of arts, science and charitable organisations. If you would like to watch Mr Yates video please visit our YouTube channel, or follow the link here: https://youtu.be/G1FksGyRMCw
Dr Gregory Cole from the David Geffen School of Medicine is currently a Professor of Medicine and Neurology at UCLA where he is also the Associate Director of the UCLA Alzheimer's Center and Associate Director for Research at the Geriatric Research, Education and Clinical Center for the Greater Los Angeles Veterans Administration System. His work for the last two decades has been centred on the production and role of beta amyloid in Alzheimer’s Disease. His work with Neuro-Bio revolves around the proof of concept studies characterising T14 in Alzheimer’s in comparison to control brains.If you would like to watch Dr Cole's video please visit our YouTube Channel, or follow the link here: https://youtu.be/MasnVguC86o
The last video that was viewed was by Dr Richard Mohs who is currently the Chief Scientific Officer for the Global Alzheimer’s Platform Foundation. This organisation focuses on improving the speed and quality of drug development for Alzheimer’s Disease. He also serves as a consultant to academic institutions and biopharmaceutical companies. Mr Mohs is a member of the Board of Governors for the Alzheimer’s Drug Discovery Foundation and is a member of the Board of Directors of the Greater Indiana Chapter of the Alzheimer’s Association and is currently on the Science Advisory Board of Neuro-Bio.If you would like to watch Dr Mohs' video please visit our YouTube Channel, or follow the link here:https://youtu.be/fuLOnGWOnck
We would like to say a huge thank you to Venner Shipley for sponsoring the event and for their continued support with our ever-growing patent portfolio. We would also like to thank Creative Catering for providing the food and for their help on the day and Matt Whiteley of Black&Whiteley Photography for capturing the day.
If you would like any further information on the day or would like to request a download of the presentations then please contact Julie Peachey on Julie.email@example.com